Zealand Pharma A/S Zealand Pharma A/S

Zealand Pharma A/S

ZEAL

Xếp hạng trong cổ phiếu #5542
Zealand Pharma A/S is a Danish biotechnology firm dedicated to the... Zealand Pharma A/S is a Danish biotechnology firm dedicated to the identification, progression, and market introduction of peptide-based therapeutics. The company concentrates its efforts on treatments for gastrointestinal and metabolic ailments, as well as other specialized conditions where current medical options are insufficient. Its commercialized product, Dasiglucagon, is an injectable solution provided in a pre-filled syringe or autoinjector, used to address severe hypoglycemia. Furthermore, Zealand Pharma is actively developing Dasiglucagon for inclusion in bi-hormone artificial pancreas systems that integrate both insulin and dasiglucagon. The compound Dasiglucagon is also undergoing late-stage (Phase III) clinical trials for congenital hyperinsulinism. Another significant asset in its development pipeline is glepaglutide, a long-acting GLP-2 analog, which is likewise in Phase III clinical studies for treating short bowel syndrome. Founded in 1998 and headquartered in Copenhagen, Denmark, Zealand Pharma A/S maintains strategic alliances with a range of partners, including Sanofi-Aventis Deutschland GmbH, Boehringer Ingelheim International GmbH, Alexion Pharmaceuticals, Inc., and Beta Bionics, Inc.
Giá cổ phiếu
$34.66
Vốn hóa thị trường
$2.41B
Thay đổi (1 ngày)
-0.73%
Thay đổi (1 năm)
-52.10%
Quốc gia
DK
Giao dịch Zealand Pharma A/S (ZEAL)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của Zealand Pharma A/S (ZEAL)
Giá đóng cửa cao nhất: $36.07 vào 2026-10-01

Giá đóng cửa thấp nhất: $14.13 vào 2013-02-01
Lịch sử giá cổ phiếu của Zealand Pharma A/S từ 2013 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -28.90%
2025 -27.05%
2024 103.83%
2023 83.97%
2022 12.44%
2021 -30.48%
2020 12.58%
2019 163.90%
2018 -13.34%
2017 -14.27%
2016 -23.32%
2015 66.31%
2014 25.21%
2013 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.18 23.62%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $251.29 835.90%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $137.83 -3.78%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $890.85 9.42%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $766.95 9.01%
CH